Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from BioPortfolio

17:32 EDT 18th June 2018 | BioPortfolio

Here are the most relevant search results for "BioPortfolio" found in our extensive news archives from over 250 global news sources.

More Information about BioPortfolio on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioPortfolio for you to read. Along with our medical data and news we also list BioPortfolio Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioPortfolio Companies for you to search.

Showing News Articles 1–25 of 4,700+ from BioPortfolio

Wednesday 2nd May 2018

HeartSciences Announces Professor Peter Macfarlane Joins Clinical Advisory Board

Southlake, Texas – May 2, 2018 – HeartSciences, a U.S.-based medical device company that is leading innovation in the field of electrocardiology through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence, announced today that Peter W. Macfarlane has joined its board of clinical advisors.  Professor Peter W. Macfarlane, DSc eF...

Sleek, new blue G:BOX multi-application imaging range from Syngene - Produces real images for accurate quantification of DNA, visible proteins & Western blots

May 1st 2018 Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to introduce its new look G:BOX range of upgradeable multi-application  imaging systems. Designed with a sleek new darkroom, each of these systems includes top quality imaging features, making it easy for scientists to accurately quantify DNA and protein on all types of gels and bl...

Thursday 12th April 2018

LYTIX BIOPHARMA TO PRESENT DATA ON “TURNING COLD TUMORS HOT” AT AACR 2018

Oslo – April 11 - Lytix Biopharma, an immune-oncology company focused on using oncolytic peptides to induce immunogenic cancer cell death , will present data at the 2018 American Association for Cancer Research (AACR) Annual Meeting taking place from 14th – 18th April 2018 at McCormick Place North/South, Chicago, Illinois, US. Dr Mikael J. Pittet,  Associate Professor at Ha...

Tuesday 10th April 2018

HeartSciences Announces Publication of Clinical Study Results in the Journal of the American College of Cardiology (JACC)

Study demonstrates promising new capabilities for MyoVista® ECG device in detecting Abnormal Cardiac Function SOUTHLAKE, Texas, April 10, 2018 - (BioPortfolio) HeartSciences, a medical device company leading innovation in electrocardiography through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence announced today the results of a c...

Wednesday 28th March 2018

An effective model to study nanoparticle toxicity using stem cells

Nanomaterials in the form of engineered nanoparticles have been used in many daily consumer products including medical devices and diagnostics, anti-bacterial, food preservatives and packaging, household consumables. These particles are very small in size (<100 nm) and can easily enter the cell by direct uptake or by phagocytosis. After a significant number of nanoparticles enter the cells, t...

Thursday 8th March 2018

HeartSciences Announces Poster Presentation at the 2018 American College of Cardiology Scientific Sessions

HeartSciences also participates in the ACC Future Hub at Booth#3517, Space FH7 SOUTHLAKE, Texas, March 8, 2018 --(BUSINESSWIRE)—HeartSciences, an innovative medical device company, announced today that an abstract describing the detection of cardiac mechanical relaxation abnormalities using a 12-lead resting ECG that incorporates wavelet signal processing has been selected for a poster p...

As global topical and transdermal business booms, MedPharm ramps up investment at Durham, NC site

World leading service provider invests in $0.75M cutting edge instrumentation to further automated testing and expands workforce. MedPharm, the world leader in formulation and development services for topical and transdermal products, has announced internal investment of $0.75M on cutting edge instrumentation for its US facilities based in Durham, North Carolina. The investment covers the lat...

Monday 26th February 2018

Mundipharma’s novel device, k-haler®, recognised for innovative packaging by iF DESIGN AWARDS

CAMBRIDGE, 26 February 2018 – iF DESIGN AWARDS, one of the most important design awards in the world, have named the Mundipharma International Limited, which is part of the Mundipharma network of independent associated companies, amongst their winners. The k-haler® device triumphed in the Packaging Design discipline of the Medicine / Pharmaceutics category and was recognised for its...

Tuesday 20th February 2018

Positive Phase I results from Kancera for first in class immunoregulating drug KAND567 targeting fraktalkine pathway

Kancera AB (publ) reports positive results from a Phase I study in healthy subjects with its lead immunoregulating drug candidate KAND567. KAND567 is an orally available small molecule that blocks CX3CR1, the Fractalkine receptor. Fractalkine is an immunomodulating factor, known as a chemokine, which transmits signals via the CX3CR1 receptor, thereby controlling the function of immune cells and ...

Wednesday 14th February 2018

Medpharm make £1M topical formulation lab expansion investment

MedPharm announces 60% expansion of its formulation development laboratory facilities MedPharm, the world leader in formulation and development services for topical and transdermal products, has announced a laboratory expansion following an internal investment of £1 million to increase its laboratory footprint in the UK by 60%. The expansion is to accommodate the new scientists needed to...

Syngene Introduces New Red InGenius3 Gel Doc Compact, Cost-Effective System puts Scientists in Control of their Gel Imaging

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to introduce its new red InGenius3 gel documentation system. Designed with a small darkroom which scientists can use with a choice of UV, blue and white lighting, the InGenius3 is excellent for laboratories looking for a versatile, budget system to accurately image both DNA and protein gels. The InGe...

Monday 12th February 2018

Kinetics - The Desire to Move - A film to raise awareness of living with Parkinson's Disease

DT2 Productions (http://www.dt2productions.co.uk/) have recently released an innovation film "Kinetics" to give people living with Parkinson’s Disease a voice and raise awareness about this often misunderstood condition. Kinetics (https://www.youtube.com/watch?v=R8tIp409QBM) was written and performed by Sue Wylie, who was diagnosed with early onset Parkinson’s shortly ...

Monday 5th February 2018

Kinapse responds to clinical trial data anonymization challenge with timely webinar

Best-practice webinar on EMA Policy 0070 compliance will feature first-hand accounts of some of the experiences and lessons learnt from 21 external submissions made by 9 pharma firms London, UK – February 5th, 2018 - Kinapse, the global consulting and operational services provider to the Life Sciences market, is to host a practical webinar illustrating how life sciences companies are man...

Monday 29th January 2018

Follicum identifies receptors in insulin-producing cells for potential new class of diabetes drugs

Lund, Sweden, January 29, 2018: Follicum AB ("Follicum") today announced that it has successfully mapped the receptors in insulin-producing cells that bind the company’s peptides. The new knowledge represents an important milestone in the continued development of the company's diabetes project and opens the possibility of the identified receptors becoming potential drug targe...

Thursday 25th January 2018

d-Wise VP of Life Sciences, Chris Decker, is Appointed to the CDISC Board of Directors

The 10-year VP of Life Sciences at d-Wise is honored to have been selected to further the impactful mission of CDISC Morrisville, NC, - Jan. 25, 2018 - d-Wise Technologies, Inc. announced today that Chris Decker, VP of Life Science Practices, has been appointed to the Clinical Data Interchange Standards Consortium (CDISC) Board of Directors for a three-year term, effective January 1, 2018.&nbs...

Thursday 18th January 2018

Important new receptors for Follicum’s lead candidate FOL-005 in hair follicle cells identified

Lund, Sweden, January 18, 2018. Follicum AB ("Follicum") today announced that new proteomics research has identified receptors in human hair follicle cells that its lead candidate FOL-005 binds to. The newly acquired knowledge paves the way for a better understanding of how FOL-005 can be used for treatment of hair loss, and a significant milestone in the continued development of FOL-0...

Locate Therapeutics Successfully Achieves ISO 13845 Certification for Design, Development and Control of Manufacture for Resorbable Biomaterials Proprietary Matrix TAOS® Offers Multiple Benefits in Delivery of Advanced Therapeutics for Regenerative Medic

Nottingham UK, January 18, 2018, Locate Therapeutics, a leading UK regenerative medicine company has announced that it has successfully achieved EN ISO 13845:2016 certification for the design control and control of manufacturing of resorbable injectable tissue scaffolds for use in bone repair and regeneration. Currently Locate is developing a pipeline of combination therapies using its patented ...

Wednesday 17th January 2018

New study shows GA-Map gut microbial composition test successfully identifies IBS patients that can benefit from FODMAP diet

Oslo January 17, 2018:) Genetic Analysis (GA), a leading Microbiome MDx specialist, today announced the publication of a new study in the peer-reviewed journal Digestive Disease and Sciences showing the results of using its GA-map™ Dysbiosis Test for identifying IBS patients who respond to the FODMAP diet and thus receive symptom relief. At least 10% of the general population is affected b...

Monday 15th January 2018

MedPharm launches new automated performance testing services, MedStat-HTTM and MedFlux-HT® for de-risking and accelerating the development of topical medicines

MedPharm, the world leader in formulation and in vitro performance testing of topical medicines, has launched two automated testing services, MedStat-HT and MedFlux-HT® to de-risk client’s development programs and shorten development timelines. Both pieces of equipment incorporated design features which provide significant improvements over commercially available systems. MedFlux-HT...

Tuesday 2nd January 2018

New QuickQuant Feature in GeneSys Software Saves Time with Easy-to-Use Analysis alongside Image Capture

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to announce its GeneSys software has been upgraded to include QuickQuant, a new feature for rapid band quantification analysis on blots or gels. This software, available to download free of charge to existing users of specified Syngene imaging systems, saves scientists time by allowing them to accurate...

Tuesday 19th December 2017

NEW Syngene GeneGnome XRQ Chemiluminescence Imaging System Offers Quick and Easy Chemi Blot Imaging with Minimal Training

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to introduce its new GeneGnome XRQ, a dedicated chemiluminescence imaging system designed to rapidly and accurately image chemiluminescent Western blots. The new, blue GeneGnome XRQ houses a high-quality F/0.95 fixed focus, cooled camera with on chip integration and GeneSys software, all packed into ...

Tuesday 12th December 2017

IDEX Health & Science Announces Acquisition of New Microfluidics Company

Rohnert Park, CA, December 11, 2017 — IDEX Health & Science, LLC  today announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business. Located in Zweibrücken, Germany, thinXXS  Microtechnology is a leader in the development and production of plastic microfluidic consumables serving the Life Sciences, Point o...

Microbiome MDx specialist Genetic Analysis signs supply & distribution agreement with Bio-Rad for GA-Map™

Dysbiosis success triggers further investment and development agreement for additional microbiome tests beyond GA-map™ dysbiosis Test (Oslo and Hercules, Calif., 12 December 2017) Genetic Analysis (GA) and Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced that they have signed a supply and distribution agreement for ...

Friday 1st December 2017

Copley Scientific to showcase new TPK™ 2100 Critical Flow Controller for dry powder inhaler testing at DDL2017

A highly automated system to speed up testing, improve reproducibility, and enhance data output and recording Monday 27th November: Nottingham, UK: Copley Scientific, the world’s leading manufacturer of inhaler test equipment, will be presenting its new 3rd generation Critical Flow Controller – the TPK™ 2100 – for the testing of dry powder inhalers (DPIs) at the 2017 Dr...

Copley Scientific introduces new, upgraded breath simulators for inhaled product testing.

13th November 2017: Nottingham, UK: Copley Scientific, the world’s leading manufacturer of inhaler test equipment, launches new advanced breath simulators, the BRS 2100 and BRS 3100, for orally inhaled product (OIP) development and testing. In recent years, in response to regulatory and pharmacopoeial changes, and the drive to ensure closer correlation between in vivo and in vitro performa...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks